China Pharma Holdings (CPHI) Accumulated Expenses (2016 - 2025)
Historic Accumulated Expenses for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $170426.0.
- China Pharma Holdings' Accumulated Expenses fell 8642.57% to $170426.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $170426.0, marking a year-over-year decrease of 8642.57%. This contributed to the annual value of $247159.0 for FY2024, which is 1729.08% down from last year.
- Latest data reveals that China Pharma Holdings reported Accumulated Expenses of $170426.0 as of Q3 2025, which was down 8642.57% from $191293.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Accumulated Expenses ranged from a high of $1.3 million in Q3 2024 and a low of $110387.0 during Q2 2022
- In the last 5 years, China Pharma Holdings' Accumulated Expenses had a median value of $195264.0 in 2025 and averaged $256629.3.
- In the last 5 years, China Pharma Holdings' Accumulated Expenses surged by 94914.89% in 2024 and then crashed by 8642.57% in 2025.
- China Pharma Holdings' Accumulated Expenses (Quarter) stood at $298452.0 in 2021, then soared by 35.64% to $404807.0 in 2022, then dropped by 26.18% to $298829.0 in 2023, then dropped by 17.29% to $247159.0 in 2024, then plummeted by 31.05% to $170426.0 in 2025.
- Its last three reported values are $170426.0 in Q3 2025, $191293.0 for Q2 2025, and $195264.0 during Q1 2025.